The role of p38 MAPK and JNK in arsenic trioxide-induced mitochondrial cell death in human cervical cancer cells

Journal of Cellular Physiology

Volumn 217, Issue 1, 2008, Pages 23-33

  Kang, Young Hee ^a   Lee, Su Jae ^a  

^a Hanyang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 NITROPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ACETYLCYSTEINE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; ARSENIC TRIOXIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN BAX; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; ANTINEOPLASTIC AGENT; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; ORGANOARSENIC DERIVATIVE; OXIDE;

ARTICLE; CELL DEATH; ENZYME ACTIVATION; ENZYME INHIBITION; FEMALE; HELA CELL; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; UTERINE CERVIX CANCER; APOPTOSIS; DRUG EFFECT; GENETIC TRANSFECTION; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN TRANSPORT; UTERINE CERVIX TUMOR; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; ARSENICALS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; ENZYME ACTIVATION; FEMALE; HELA CELLS; HUMANS; MAP KINASE KINASE 4; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; OXIDES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-BCL-2; REACTIVE OXYGEN SPECIES; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSFECTION; UTERINE CERVICAL NEOPLASMS;

EID: 49649085319     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21470     Document Type: Article

References (67)

1. Abe J, Takahashi M, Ishida M, Lee JD, Berk BC. 1997. c-Src is required for oxidative stress-mediated activation of big mitogen-activated protein kinase I. J Biol Chem 272:20389-20394.
2. Antman KH. 2001. Introduction: The history of arsenic trioxide in cancer therapy. Oncologist 6:1-2.
3. Antonsson B, Martinou JC. 2000. The Bcl-2 protein family. Exp Cell Res 256:50-57.
4. Basu A, You SA, Haldar S. 2000. Regulation of Bcl-2 phosphorylation by stress response kinase pathway. Int J Oncol 16:497-500.
5. Bernstam L, Nriagu J. 2000. Molecular aspects of arsenic stress. J Toxicol Environ Health B Crit Rev 3:293-322.
6. Blagosklonny MV. 2001. Unwinding the loop of Bcl-2 phosphorylation. Leukemia 15: 869-874.
7. Blagosklonny MV, Schulte T, Nguyen P, Trepel J, Neckers LM. 1996. Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway. Cancer Res 56:1851-1854.
8. Blagosklonny MV, Giannakakou P, el-Deiry WS, Kingston DG, Higgs PI, Neckers L, Fojo T. 1997. Raf-1/bcl-2 phosphorylation: A step from microtubule damage to cell death. Cancer Res 57:130-135.
9. Bode AM, Dong Z. 2005. Signal transduction pathways in cancer development and as targets for cancer prevention. Prog Nucleic Acid Res Mol Biol 79:237-297.
10. Choi SY, Kim MJ, Kang CM, Bae S, Cho CK, Soh JW, Kim JH, Kang S, Chung HY, Lee YS, Lee SJ. 2006. Activation of Bak and Bax through c-abl-protein kinase Cdelta-p38 MAPK signaling in response to ionizing radiation in human non-small cell lung cancer cells. J Biol Chem 281:7049-7059.
11. Chou WC, Jie C, Kenedy AA, Jones RJ, Trush MA, Dang CV. 2004. Role of NADPH oxidase in arsenic-induced reactive oxygen species formation and cytotoxicity in myeloid leukemia cells. Proc Natl Acad Sci USA 101:4578-4583.
12. 3). FEBS Lett 519:195-200.
13. Cobb MH. 1999. MAP kinase pathways. Prog Biophys Mol Biol 71:479-500.
14. Cory S, Huang DC, Adams JM. 2003. The Bcl-2 family: Roles in cell survival and oncogenesis. Oncogene 22:8590-8607.
15. Dai J, Weinberg RS, Waxman S, Jing Y. 1999. Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system. Blood 93:268-277.
16. Danial NN, Korsmeyer SJ. 2004. Cell death: Critical control points. Cell 116:205-219.
17. Deng X, Gao F, Flagg T, Anderson J, May WS. 2006. Bcl2's flexible loop domain regulates p53 binding and survival. Mol Cell Biol 26:4421-4434.
18. Desagher S, Osen-Sand A, Nichols A, Eskes R, Montessuit S, Lauper S, Maundrell K, Antonsson B, Martinou JC. 1999. Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J Cell Biol 144:891-901.
19. Dewson G, Snowden RT, Almond JB, Dyer MJ, Cohen GM. 2003. Conformational change and mitochondrial translocation of Bax accompany proteasome inhibitor-induced apoptosis of chronic lymphocytic leukemic cells. Oncogene 22:2643-2654.
20. Ghatan S, Larner S, Kinoshita Y, Hetman M, Patel L, Xia Z, Youle RJ, Morrison RS. 2000. p38 MAP kinase mediates bax translocation in nitric oxide-induced apoptosis in neurons. J Cell Biol 150:335-347.
21. Green DR, Reed JC. 1998. Mitochondria and apoptosis. Science 281:1309-1312.
22. Gross A, McDonnell JM, Korsmeyer SJ. 1999. BCL-2 family members and the mitochondria in apoptosis. Genes Dev 13:1899-1911.
23. Guo B, Godzik A, Reed JC. 2001. Bcl-G, a novel pro-apoptotic member of the Bcl-2 family. J Biol Chem 276:2780-2785.
24. Haldar S, Jena N, Croce CM. 1995. Inactivation of Bcl-2 by phosphorylation. Proc Natl Acad Sci USA 92:4507-4511.
25. Haldar S, Chintapalli J, Croce CM. 1996. Taxol induces bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res 56:1253-1255.
26. Hengartner MO. 2000. The biochemistry of apoptosis. Nature 407:770-776.
27. Hsu YT, Youle RJ. 1998. Bax in murine thymus is a soluble monomeric protein that displays differential detergent-induced conformations. J Biol Chem 273:10777-10783.
28. Hundley TR, Rigas B. 2006. Nitric oxide-donating aspirin inhibits colon cancer cell growth via mitogen-activated protein kinase activation. J Pharmacol Exp Ther 316:25-34.
29. Ito T, Deng X, Carr B, May WS. 1997. Bcl-2 phosphorylation required for anti-apoptosis function. J Biol Chem 272:11671-11673.
30. Ito K, Hirao A, Arai F, Takubo K, Matsuoka S, Miyamoto K, Ohmura M, Naka K, Hosokawa K, Ikeda Y, Suda T. 2006. Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nat Med 12:446-451.
31. Jabs T. 1999. Reactive oxygen intermediates as mediators of programmed cell death in plants and animals. Biochem Pharmacol 57:231-245.
32. Jäger R, Herzer U, Schenkel J, Weiher H. 1997. Overexpression of Bcl-2 inhibits alveolar cell apoptosis during involution and accelerates c-myc-induced tumorigenesis of the mammary gland in transgenic mice. Oncogene 15:1787-1795.
33. Jing Y, Dai J, Chalmers-Redman RM, Tatton WG, Waxman S. 1999. Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway. Blood 94:2102-2111.
34. Kang YH, Yi MJ, Kim MJ, Park MT, Bae S, Kang CM, Cho CK, Park IC, Park MJ, Rhee CH, Hong SI, Chung HY, Lee YS, Lee SJ. 2004. Caspase-independent cell death by arsenic trioxide in human cervical cancer cells: Reactive oxygen species-mediated poly(ADP-ribose) polymerase-1 activation signals apoptosis-inducing factor release from mitochondria. Cancer Res 64:8960-8967.
35. Ke N, Godzik A, Reed JC. 2001. Bcl-B, a novel Bcl-2 family member that differentially binds and regulates Bax and Bak. J Biol Chem 276:12481-12484.
36. Kogan SC, Brown DE, Shultz DB, Truong BT, Lallemand-Breitenbach V, Guillemin MC, Lagasse E, Weissman IL, Bishop JM. 2001. BCL-2 cooperates with promyelocyte leukemia retinoic acid receptor alpha chimeric protein (PMLRARalpha) to block neutrophil differentiation and initiate acute leukemia. J Exp Med 193:531-543.
37. Kroemer G, Reed JC. 2000. Mitochondrial control of cell death. Nat Med 6:513-519.
38. Kyriakis JM, Avruch J. 2001. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 81:807-869.
39. Lee LF, Li G, Templeton DJ, Ting JP. 1998. Paclitaxel (Taxol)-induced gene expression and cell death are both mediated by the activation of c-Jun NH2-terminal kinase (JNK/SAPK). J Biol Chem 273:28253-28260.
40. 3) in the orthotopic metastasis model of androgen-independent prostate cancer. Cancer Res 61:5432-5440.
41. 2-induced phosphorylation of ERK1/2 and PKB requires tyrosine kinase activity of insulin receptor and c-Src. Antioxid Redox Signal 7:1014-1020.
42. Murphy KM, Streips UN, Lock RB. 1999. Bax membrane insertion during Fas(CD95)-induced apoptosis precedes cytochrome c release and is inhibited by Bcl-2. Oncogene 18:5991-5999.
43. Murphy KM, Streips UN, Lock RB. 2000. Bcl-2 inhibits a Fas-induced conformational change in the Bax N terminus and Bax mitochondrial translocation. J Biol Chem 275:17225-17228.
44. Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T, Tokino T, Taniguchi T, Tanaka N. 2000. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288:1053-1058.
45. Park MT, Choi JA, Kim MJ, Um HD, Bae S, Kang CM, Cho CK, Kang S, Chung HY, Lee YS, Lee SJ. 2003. Suppression of extracellular signal-related kinase and activation of p38 MAPK are two critical events leading to caspase-8- and mitochondria-mediated cell death in phytosphingosine-treated human cancer cells. J Biol Chem 278:50624-50634.
46. Ruvolo PP, Deng X, Carr BK, May WS. 1998. A functional role for mitochondrial protein kinase Calpha in Bcl2 phosphorylation and suppression of apoptosis. J Biol Chem 273:25436-25442.
47. Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y, Kawabata M, Miyazono K, Ichijo H. 1998. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) I. EMBO J 17:2596-2606.
48. Sato T, Hanada M, Bodrug S, Irie S, Iwama N, Boise LH, Thompson CB, Golemis E, Fong L, Wang HG, et al. 1994. Interactions among members of the Bcl-2 protein family analyzed with a yeast two-hybrid system. Proc Natl Acad Sci USA 91:9238-9242.
49. Shen ZY, Shen J, Cai WJ, Hong C, Zheng MH. 2000. The alteration of mitochondria is an early event of arsenic trioxide induced apoptosis in esophageal carcinoma cells. Int J Mol Med 5:155-158.
50. Shen Y, Shen ZX, Yan H, Chen J, Zeng XY, Li JM, Li XS, Wu W, Xiong SM, Zhao WL, Tang W, Wu F, Liu YF, Niu C, Wang ZY, Chen SJ, Chen Z. 2001. Studies on the clinical efficacy and pharmacokinetics of low-dose arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia: A comparison with conventional dosage. Leukemia 15:735-741.
51. Song JJ, Rhee JG, Suntharalingam M, Walsh SA, Spitz DR, Lee YJ. 2002. Role of glutaredoxin in metabolic oxidative stress. Glutaredoxin as a sensor of oxidative stress mediated by H2 O2. J Biol Chem 277:46566-46575.
52. Srivastava RK, Srivastava AR, Korsmeyer SJ, Nesterova M, Cho-Chung YS, Longo DL. 1998. Involvement of microtubules in the regulation of Bcl2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase. Mol Cell Biol 18:3509-3517.
53. Srivastava RK, Mi QS, Hardwick JM, Longo DL. 1999. Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosis. Proc Natl Acad Sci USA 96:3775-3780.
54. Suzaki Y, Yoshizumi M, Kagami S, Koyama AH, Taketani Y, Houchi H, Tsuchiya K, Takeda E, Tamaki T. 2002. Hydrogen peroxide stimulates c-Src-mediated big mitogen-activated protein kinase 1 (BMK1) and the MEF2C signaling pathway in PC12 cells: Potential role in cell survival following oxidative insults. J Biol Chem 277:9614-9621.
55. Tibbles LA, Woodgett JR. 1999. The stress-activated protein kinase pathways. Mol Life Sci 55:1230-1254.
56. Tobiume K, Matsuzawa A, Takahashi T, Nishitoh H, Morita K, Takeda K, Minowa O, Miyazono K, Noda T, Ichijo H. 2001. ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep 2:222-228.
57. Torres M. 2003. Mitogen-activated protein kinase pathways in redox signaling. Front Biosci 8:d369-d391.
58. Ueda S, Masutani H, Nakamura H, Tanaka T, Ueno M, Yodoi J. 2002. Redox control of cell death. Antioxid Redox Signal 4:405-414.
59. Uslu R, Sanli UA, Sezgin C, Karabulut B, Terzioglu E, Omay SB, Goker E. 2000. Arsenic trioxide-mediated cytotoxicity and apoptosis in prostate and ovarian carcinoma cell lines. Clin Cancer Res 6:4957-4964.
60. van Delft MF, Huang DC. 2006. How the Bcl-2 family of proteins interact to regulate apoptosis. Cell Res 16:203-213.
61. Van Laethem A, Van Kelst S, Lippens S, Declercq W, Vandenabeele P, Janssens S, Vandenheede JR, Garmyn M, Agostinis P. 2004. Activation of p38 MAPK is required for Bax translocation to mitochondria, cytochrome c release and apoptosis induced by UVB irradiation in human keratinocytes. FASEB J 18:1946-1948.
62. Waxman S, Anderson KC. 2001. History of the development of arsenic derivatives in cancer therapy. Oncologist 6:3-10.
63. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB, Korsmeyer SJ. 2001. Proapoptotic BAX and BAK: A requisite gateway to mitochondrial dysfunction and death. Science 292:727-730.
64. Yamaguchi H, Wang HG. 2001. The protein kinase PKB/Akt regulates cell survival and apoptosis by inhibiting Bax conformational change. Oncogene 20:7779-7786.
65. Yamaguchi H, Wang HG. 2002. Bcl-XL protects BimEL-induced Bax conformational change and cytochrome C release independent of interacting with Bax or BimEL. J Biol Chem 277:41604-41612.
66. Yin XM, Oltvai ZN, Korsmeyer SJ. 1994. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 369:321-323.
67. Yoshino T, Kishi H, Nagata T, Tsukada K, Saito S, Muraguchi A. 2001. Differential involvement of p38 MAP kinase pathway and Bax translocation in the mitochondria-mediated cell death in TCR- and dexamethasone-stimulated thymocytes. Eur J Immunol 31:2702-2708.